Atlas Trials

Refractory Primary Vitreoretinal DLBCL

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Primary Vitreoretinal DLBCL

RecordFirmDate
Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma (NCT03798314)Mayo Clinic2019-01-30

Track Refractory Primary Vitreoretinal DLBCL automatically

Every clearance here is in the API, with alerts when new ones post.